Table 1.

Clinical characteristics of patients receiving lenvatinib.

Characteristics
Total number	40
Female:Male	27:13
Age (years)	63.0 ± 10.9 (33–78)
Body weight (kg)	56.0 ± 11.0 (35–82)
Laboratory test values at lenvatinib initiation
Aspartate transaminase (IU/L)	25.9 ± 8.9 (13–56)
Alanine transaminase (IU/L)	22.3 ± 9.1 (11–45)
Serum albumin (g/dL)	3.9 ± 0.5 (2.7–5.1)
Total bilirubin (mg/dL)	0.6 ± 0.2 (0.4–1.5)
Serum creatinine (mg/dL)	0.76 ± 0.29 (0.41–1.78)
ABCB1 1236C > T	C/C: C/T: T/T = 8: 22: 10
ABCB1 2677G > T/A	G/G: G/T: G/A: T/T: T/A: A/A = 9: 15: 4: 4: 5: 3
ABCB1 3435C > T	C/C: C/T: T/T = 14: 21: 5
ABCG2 421C > A	C/C: C/A: A/A = 20: 18: 2
ABCC2 −24C > T	C/C: C/T: T/T = 24: 14: 2
CYP3A4 20230 G > A(*1G)	*1/*1: *1/*1G: *1G/*1G = 24: 15: 1
CYP3A5 6986 A > G(*3)	*1/*1: *1/*3: *3/*3 = 1: 13: 26

Data are presented as number or mean ± standard deviation (range).